BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE

This publication has 69 references indexed in Scilit:

• Anticoagulant Actions of Tissue Factor Pathway Inhibitor on Tissue-Factor-Dependent Plasma Coagulation
  Seminars in Thrombosis and Hemostasis, 1995
• Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of Heparin
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma
  European Journal of Biochemistry, 1990
• New carbohydrate site in mutant antithrombin (7 Ile→Asn) with decreased heparin affinity
  FEBS Letters, 1988
• Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
  Journal of Clinical Investigation, 1988
• Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: Evidence for conformational peculiarity of the sulfated iduronate residue
  Biochemical and Biophysical Research Communications, 1985
• Preliminary Biochemical and Pharmacologic Studies on a Chemically Synthesized Pentasaccharide
  Seminars in Thrombosis and Hemostasis, 1985
• Effect of Heparin and Heparin Fractions on Platelet Aggregation
  Journal of Clinical Investigation, 1980
• Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin
  FEBS Letters, 1976
• The separation of active and inactive forms of heparin
  Biochemical and Biophysical Research Communications, 1976